{"nct_id":"NCT01313650","title":"A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD","status":"COMPLETED","status_verified_date":"2018-08","start_date":"2011-03-01","start_date_type":null,"primary_completion_date":"2012-04-01","primary_completion_date_type":"ACTUAL","completion_date":"2012-04-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}